NasdaqGM - Delayed Quote USD

VanEck Pharmaceutical ETF (PPH)

86.80 +0.28 (+0.32%)
At close: April 26 at 4:00 PM EDT
Key Events
Loading Chart for PPH
DELL
  • Previous Close 86.52
  • Open 86.52
  • Bid 86.64 x 200
  • Ask 86.80 x 400
  • Day's Range 86.34 - 87.06
  • 52 Week Range 74.05 - 91.16
  • Volume 616,485
  • Avg. Volume 137,582
  • Net Assets 543.21M
  • NAV 86.78
  • PE Ratio (TTM) 20.97
  • Yield 1.87%
  • YTD Daily Total Return 7.32%
  • Beta (5Y Monthly) 0.60
  • Expense Ratio (net) 0.36%

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

VanEck

Fund Family

Health

Fund Category

543.21M

Net Assets

2011-12-20

Inception Date

Performance Overview: PPH

Trailing returns as of 4/26/2024. Category is Health.

YTD Return

PPH
7.32%
Category
6.33%
 

1-Year Return

PPH
12.93%
Category
11.04%
 

3-Year Return

PPH
9.34%
Category
0.38%
 

People Also Watch

Holdings: PPH

Top 10 Holdings (63.83% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 11.78%
NVO
Novo Nordisk A/S 9.44%
JNJ
Johnson & Johnson 6.68%
MRK
Merck & Co., Inc. 6.24%
ABBV
AbbVie Inc. 6.08%
AZN
AstraZeneca PLC 5.15%
NVS
Novartis AG 4.72%
COR
Cencora, Inc. 4.62%
MCK
McKesson Corporation 4.56%
PFE
Pfizer Inc. 4.55%

Sector Weightings

SectorPPH
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: PPH

Research Reports: PPH

  • VRSN: Raising target price to $194.00

    VERISIGN INC has an Investment Rating of HOLD; a target price of $194.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • RMBS: Lowering target price to $62.00

    RAMBUS INC has an Investment Rating of HOLD; a target price of $62.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • RMBS: Raising target price to $65.00

    RAMBUS INC has an Investment Rating of HOLD; a target price of $65.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • VRSN: Raising target price to $201.00

    VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

Related Tickers